Memorial Sloan-Kettering Cancer Center

Radiation May Help When Prostate Cancer Returns It halved the death rate and might need to be used more often, researchers say By Ed Edelson HealthDay Reporter TUESDAY, June 17 (HealthDay News) -- Countering common medical theory, a new study finds that radiation therapy may save the lives of many men whose prostate cancer recurs aggressively after surgery. "We show that even men with aggressive disease that recurs after surgery seem to benefit from salvage radiotherapy," said lead... Read Full Story

Nobel Laureate and Friesen Prize Winner Urges Importance of Medical Science to Change Global Health Canada NewsWire 09-19-08 TORONTO, Sep. 19, 2008 (Canada NewsWire via COMTEX) -- Nobel Prize winning scientist and renowned cancer researcher, Dr. Harold Varmus, is optimistic that global health in developing countries will improve by encouraging medical science within these countries, increasing access to medical information, and by funding large networks of scientists to help determine the... Read Full Story

New research from at Memorial Sloan-Kettering Cancer Center in New York City suggests that hormone deprivation therapy, which is commonly used to treat prostate cancer, may adversely affect cognition in patients. The finding that hormone deprivation therapy may impair the ability to recall and concentrate in some patients results from a review of previous studies, appearing in the journal CANCER. Dr. Christian Nelson, a psychologist behind the review, suggests clinicians and patients to be... Read Full Story

  Prostate cancer therapy may impair cognition Last Updated: 2008-07-28 12:00:46 -0400 (Reuters Health) NEW YORK (Reuters Health) - Up to 69 percent of men who receive hormone deprivation therapy for prostate cancer will experience some degree of cognitive impairment, such as in the ability to concentrate, a review of published data suggests. Men with recurrent or advanced prostate cancer may be put on hormone therapy to block testosterone production in an effort to halt or slow the growth... Read Full Story

The Hormone deprivation therapy, also known as androgen depletion therapy, basically involves androgen depletion through chemical castration with drugs such as leuprolide and goserelin. Prostate cancer patients who are prescribed these drugs often stay on them for the duration of their life, and the researchers have been documenting the potential adverse effects associated with their use. New research from at Memorial Sloan-Kettering Cancer Center in New York City suggests that hormone... Read Full Story